Fairfield Financial Advisors, LTD Amgen Inc Transaction History

Fairfield Financial Advisors, LTD

$294 Billion
Q3 2024

A detailed history of Fairfield Financial Advisors, LTD transactions in Amgen Inc stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 8,284 shares of AMGN stock, worth $2.32 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

8,284

Previous 8,091 2.39%

Holding current value

$2.32 Million

Previous $2.53 Billion 5.58%

% of portfolio

0.91%

Previous 0.74%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$309.38 - $337.38 $59,710 - $65,114	193 Added 2.39%	8,284 $2.67 Billion
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $2.13 Million - $2.58 Million	8,091 New	8,091 $2.53 Billion
Q4 2023 Nov 04, 2024	BUY	$255.7 - $288.46 $77,477 - $87,403	303 Added 4.33%	7,294 $2.1 Billion
Q3 2023 Nov 04, 2024	BUY	$218.65 - $271.46 $140,810 - $174,820	644 Added 10.15%	6,991 $1.88 Billion
Q2 2023 Nov 04, 2024	SELL	$214.27 - $253.37 $415,040 - $490,777	-1,937 Reduced 23.38%	6,347 $1.41 Billion
Q1 2023 Nov 04, 2024	SELL	$225.79 - $275.2 $775,588 - $945,312	-3,435 Reduced 41.47%	4,849 $1.17 Billion
Q4 2022 Oct 07, 2024	BUY	$229.03 - $291.01 $88,863 - $112,911	388 Added 10.1%	4,230 $1.11 Billion
Q3 2022 Oct 07, 2024	SELL	$224.46 - $253.15 $953,730 - $1.08 Million	-4,249 Reduced 52.52%	3,842 $866 Million
Q2 2022 Oct 07, 2024	SELL	$230.71 - $256.74 $1.09 Million - $1.21 Million	-4,718 Reduced 58.31%	3,373 $821 Million
Q1 2022 Oct 07, 2024	SELL	$219.27 - $242.57 $1.01 Million - $1.12 Million	-4,605 Reduced 56.92%	3,486 $843 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.

Account

Fairfield Financial Advisors, LTD Amgen Inc Transaction History